Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (DE:471A)
FRANKFURT:471A
Holding DE:471A?
Track your performance easily
471A Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.99 - €3.26
Previous Close€3.12
Volume0.00
Average Volume (3M)1.21K
Market Cap
€275.69M
Enterprise Value€226.29M
Total Cash (Recent Filing)$65.99M
Total Debt (Recent Filing)$13.57M
Price to Earnings (P/E)―
Beta0.87
Next Earnings
Mar 26, 2025EPS Estimate
-€0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding83,942,407
10 Day Avg. Volume0
30 Day Avg. Volume1,214
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)4.26
Price to Sales (P/S)1246.63
Price to Cash Flow (P/CF)-5.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue962.93
Enterprise Value/Gross Profit641.05
Enterprise Value/Ebitda-3.64
Forecast
1Y Price Target
€18.63Price Target Upside497.20% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
aTyr Pharma News
PremiumCompany Announcements
aTyr Pharma Reports Q3 2024 Financial Results
Options Prices
Currently, No data available
---
Ownership Overview
2.65% Insiders
29.94% Mutual Funds
3.20% Other Institutional Investors
60.55% Public Companies and
Individual Investors
471A FAQ
What was aTyr Pharma’s price range in the past 12 months?
aTyr Pharma lowest stock price was €0.98 and its highest was €3.26 in the past 12 months.
What is aTyr Pharma’s market cap?
Currently, no data Available
When is aTyr Pharma’s upcoming earnings report date?
aTyr Pharma’s upcoming earnings report date is Mar 26, 2025 which is in 132 days.
How were aTyr Pharma’s earnings last quarter?
aTyr Pharma released its earnings results on Nov 07, 2024. The company reported -€0.216 earnings per share for the quarter, missing the consensus estimate of -€0.207 by -€0.009.
Is aTyr Pharma overvalued?
According to Wall Street analysts aTyr Pharma’s price is currently Undervalued.
Does aTyr Pharma pay dividends?
aTyr Pharma does not currently pay dividends.
What is aTyr Pharma’s EPS estimate?
aTyr Pharma’s EPS estimate is -€0.22.
How many shares outstanding does aTyr Pharma have?
aTyr Pharma has 83,942,406 shares outstanding.
What happened to aTyr Pharma’s price movement after its last earnings report?
aTyr Pharma reported an EPS of -€0.216 in its last earnings report, missing expectations of -€0.207. Following the earnings report the stock price went down -5.333%.
Which hedge fund is a major shareholder of aTyr Pharma?
Among the largest hedge funds holding aTyr Pharma’s share is Woodline Partners LP. It holds aTyr Pharma’s shares valued at 3M.
---
aTyr Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€18.63 (497.20% Upside)
€18.63 (497.20% Upside)
Blogger Sentiment
Bullish
DE:471A Sentiment 100%
Sector Average 72%
Sector Average 72%
Technicals
SMA
Positive
20 days / 200 days
Momentum
211.60%
12-Months-Change
Fundamentals
Return on Equity
-77.96%
Trailing 12-Months
Asset Growth
-26.75%
Trailing 12-Months
Company Description
aTyr Pharma
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
---
471A Earnings Call
Q4 2024
0:00 / 0:00
---
471A Stock 12 Month Forecast
Average Price Target
€18.63
▲(497.20% Upside)
Technical Analysis
aTyr Pharma
―
Immutep
―
Moleculin Biotech
―
Soleno Therapeutics
―
Mersana Therapeutics
―
Best Analysts Covering 471A
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+64.93%
reiterated a buy rating 7 months ago
Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +64.93% per trade.
---